Bioprogressive therapy: overbite reduction with the lower utility arch.

A series of patients treated with this appliance was investigated clinically and radiographically. True intrusion is only one factor in overbite reduction using the utility arch.

Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro-10-9359) Tigason.

In an open trial, eight patients with psoriasis took part in a four-month study to evaluate the effect of a new oral synthetic retinoid Ro-10-9359 (Tigason). All patients improved on the treatment, although one had side effects severe enough to force dosage reduction with less satisfactory control.

Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.

In an open trial, seven patients with Darier's disease took part in a three month study to evaluate the effect of a new oral synthetic retinoid. Ro 10-9359 (Tigason). The usual dose was 50 mg daily.

Intentional paraquat poisoning: case report.

A case of intentional paraquat poisoning is presented. Early treatment was instituted. At four-month follow-up, the patient was well.

Family in which Duchenne's muscular dystrophy and protan colour blindness are segregating.

A family is recorded in which Duchenne's muscular dystrophy and protan colour blindness are segregating. Of 4 members of the second generation at least one is a recombinant. The lod scores have been calculated and added to those already published.